Drawing for SOPHIA GENETICS

USPTO serial 79230427

SOPHIA GENETICS

Reviewed by CopyMark Law Group

Reg. 6748985Status 700Registered
Filing date
Status date
Registration date
Jun 7, 2022
Examiner
AYALA, LOURDES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SOPHIA GENETICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

THOMAS J MANGO

THOMAS J MANGO CANTOR COLBURN LLP20 CHURCH STREET, 22ND FLOORHARTFORD, CT 06103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents and contrast agents for medical use; chemical reagents for medical use; diagnostic biomarker reagents for diagnostics for medical use; kits containing various reagents for diagnostic tests for medical useABANDONED—
042Conducting project feasibility studies in the field of new technologies and machine learning; technical research in the field of genomics, genetics and bioinformatics, and appraisals being genetic testing for scientific research purposes; writing, design, development and updating of computer software in the field of bioinformatics; technical support concerning the use of software, namely, troubleshooting of computer software problems in the field of bioinformatics; Software as a service (SAAS) services, namely, hosting software for use by others to provide access to an online internet SaaS platform in the field of bioinformatics; provision of online nondownloadable software for use in database management and data analysis in the fields of genetics and genomics; platform as a service (PAAS) featuring computer software platforms enabling users to access software, computer networks, computer servers and computer and data storage systems and allowing the user to use them in the field of bioinformatics; provision of temporary use of non-downloadable software for importing, management and analysis of data, incorporating automatic learning and artificial intelligence components in the field of bioinformatics; provision of software (Software as a Service, SAAS) featuring software for use in database management and data analysis in the fields of genetics and genomics; software as a service (SAAS) featuring software for automatic learning and artificial intelligence to be used for data analysis in the field bioinformatics; providing scientific information in the field of genetics and genomics research information via web-based platforms; electronic data storage and cloud computing, namely, cloud computing featuring software for use in database management for bioinformatics analysis; bioinformatic analysis services being chemical and biological analysis services; development of software, and development of software for data processing in the field of bioinformatics; scientific research featuring provision of methods and tools for calculations and bioinformatics for data analysis; development and maintenance of data management software; database design in the field of bioinformatics; computer software development, namely, development of software of genomic and bioinformatic mobile applications; electronic storage of data by computer in the field of bioinformatics; and provision of advice and information for the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 23, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 9, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 15, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 15, 2022FIMPFINAL DISPOSITION PROCESSED—
Sep 7, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 7, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 7, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 29, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 1, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Mar 29, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS—
Mar 29, 2022OP.TOPPOSITION TERMINATED NO. 999999—
Mar 29, 2022OP.DOPPOSITION DISMISSED NO. 999999—
Jan 3, 2020RFNPREFUSAL PROCESSED BY IB—
Dec 12, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 10, 2019OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Dec 10, 2019OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Oct 11, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 25, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 25, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 1, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 30, 2019ALIEASSIGNED TO LIE—
May 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 22, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 16, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 16, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Oct 16, 2018CNSLSUSPENSION LETTER WRITTEN—
Sep 14, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 25, 2018RFNTREFUSAL PROCESSED BY IB—
May 7, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 7, 2018RFRRREFUSAL PROCESSED BY MPU—
May 3, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 2, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 23, 2018DOCKASSIGNED TO EXAMINER—
Apr 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 20, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 19, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance